Article
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2000
Lebrecht Antje, Grimm Christoph, Lantzsch Tilmann, Ludwig Elisabeth, Hefler Lukas, Ulbrich Eva, Koelbl Heinz
Abstract excerpt
The chemokine monocyte chemoattractant protein (MCP)-1 is thought to be involved in breast carcinogenesis. We evaluated MCP-1 serum levels in patients with breast cancer (n = 135), ductal carcinoma in situ (DCIS) I-III (n = 30), benign breast lesions (n = 143) and in healthy women (n = 27). We determined the value of MCP-1 serum levels as a differentiation marker between malignant, preinvasive and benign breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.